Tarsus Pharmaceuticals, Inc. (TARS) has 12 identified peers for comparison in the Healthcare sector. Peers include ABOS, ALDX, CNTA, CNTB, DSGN, ELDN and others.
TARS has a market capitalization of $3.14B, compared to an average peer market cap of $870.41M. TARS is significantly larger than its average peer.